HY

Hunase Yuvaraj Naveena

Active Director Director DIN 10849987
DIN 10849987 First appointment Nov 2024 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Hunase Yuvaraj Naveena

Data last updated:

Hunase Yuvaraj Naveena is a Director at Altezza Pharmaceuticals Private Limited (since 2024). The company operates in Professional Services.

DIN 10849987
Primary Designation Director
Industry Professional Services
First Appointment 26 Nov 2024
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Nov 20242022Active

Board colleagues of Hunase Yuvaraj Naveena

Directorship timeline

Open interactive timeline →
Altezza Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hunase Yuvaraj Naveena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hunase Yuvaraj Naveena

Hunase Yuvaraj Naveena currently holds 1 directorship: Altezza Pharmaceuticals Private Limited (Director, since 26 Nov 2024).

Hunase Yuvaraj Naveena was first appointed on 26 Nov 2024 as Director at Altezza Pharmaceuticals Private Limited.

The current boards of Hunase Yuvaraj Naveena's companies include Koneri Srinivasaguptha Sanjay (Altezza Pharmaceuticals Private Limited), Sripuram Venkatarathanaiah Bharathi (Altezza Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available